Research & Development is the key to the future of
pharmaceutical industry. The pharmaceutical advances for
considerable improvement in life expectancy and health all over the
world are the result of a steadily increasing investment in
research. There is considerable scope for collaborative R & D in
India. India can offer several strengths to the international R &
D community. These strengths relate to availability of excellent
scientific talents who can develop combinatorial chemistry, new
synthetic molecules and plant derived candidate drugs.
R & D in the pharmaceutical industry in India is critical to
find answers for some of the diseases peculiar to a tropical country
like India and also for finding solutions for unmet medical needs.
Industrial R & D groups can carry out limited primary screening
to identify lead molecules or even candidate drugs for further in
vivo screening, pre-clinical pharmacology, toxicology, animal and
human pharmacokinetics and metabolic studies before taking them up
for human trials. In such collaborations, harmonized standards of
screening can be assured following established good laboratory
practices.
The R & D expenditure by the Indian pharmaceutical industry is
around 1.9% of the industrys turnover. This obviously, is very
low when compared to the investment on R & D by foreign
research-based pharma companies. They spend 10 - 16% of the turnover
on R & D. However, now that India is entering into the Patent
protection area, many companies are spending relatively more on R &
D.
When it comes to clinical evaluation at the time of multi-center
trials, India would provide a strong base considering the real
availability of clinical materials in diverse therapeutic areas.
Such active collaboration will be mutually beneficial to both
partners. According to a survey by the Pharmaceutical Outsourcing
Management Association and Bio/Pharmaceutical Outsourcing Report, pharmaceutical companies are utilizing substantially the services of
Contract Research Organizations (CROs).
Indian Pharmaceutical Industry, with its rich scientific talents, provides cost-effective clinical trial research. It has an excellent
record of development of improved, cost-beneficial chemical
syntheses for various drug molecules. Some MNCs are already sourcing
these services from their Indian affiliates.
The Pharmaceutical and Biotechnology Industry is eligible for
weight deduction for R&D expense upto 150%. These R&D
companies will also enjoy tax holiday for 10 years. A promotional
research and development fund of Rs.150 crores is set up by the
Government to promote research and development in the
pharmaceuticals sector.
The
portal gives you extensive list of the cGMP contract manufacturer of herbals and
pharmaceutical manufacturing capabilities. It also contains the valuable information
pertaining to the drug manufacturing with the names of various drugs.
Pharmaceutical
Finished Formulations:
Under finished pharmaceutical formulations the drugs are manufactured
under strict quality control for ensuring a completely safe product. The
finished formulations are available in the form of tablets, capsules, injections.
Pharmaceutical
Drugs:
Pharmaceutical Drugs are those drugs that are given under the
supervision of physicians to cure various physical disorders. They are
either prescriptive or non prescriptive.